Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

avatar
shintaka1168 Private ID: 183266823
No profile added yet
Follow
    According to the session list posted on Wednesday, $Microsoft(MSFT.US)$will announce completely new artificial intelligence tools for use on PCs and clouds at the annual Build Conference.
    Microsoft's Chief Executive Officer Satya Nadella (CEO) told analysts in January that 2024 is the year “AI becomes part of the first class of all PCs,” and the schedule of the conference Microsoft will hold in May reflects that goal. Microsoft has reported a significant increase in revenue from clients running AI models on the Azure public cloud, and the company wants to maintain this trend by deploying new AI functions for developers.
    Mustafa Suleiman, the new person in charge of Microsoft AI, will be on stage with Nadella and other long-time executives during the keynote address of the show to be held in Seattle. Suleiman, the co-founder of DeepMind, an AI startup acquired by Google in 2014, experienced startup inflation last month...
    Translated
    Microsoft will announce new Windows and cloud AI features in May
    Hello Moomoo users! Thank you very much for your hard work.Today's stock price summary is as follows. Thank you in advance.
    ●The Nikkei Stock Average ended at 38807.38 yen, 111.41 yen higher than the previous business day
    ● Pay attention to the “world with interest rates” as the Bank of Japan normalization approaches, and changes occurring in markets and household finances
    ● The view is that yen depreciated in the latter half of the 147 yen range, and negative interest rates were removed and factored into the round
    ● Bonds are falling, bid results for 20-year government bonds are sluggish - Bank of Japan policy normalization observations are also heavy
    ● Attention to the handle: $Nissan Motor(7201.JP)$ $Honda Motor(7267.JP)$etc
    -MooMoo News Japan Stock Zeber
    Market Overview
    Today's Nikkei Stock Average ended at 38807.38 yen, 111.41 yen higher than the previous business day, and the Tokyo Stock Price Index (TOPIX) ended at 2661.59, 13.08 points higher than the previous business day.
    Top news
    Pay attention to the “world with interest rates” as the Bank of Japan normalization approaches, and changes occurring in markets and household finances
    The countdown to a “world with interest rates” has begun in Japan where monetary easing of a different dimension continued for over 10 years...
    Translated
    Tokyo Market Summary: Nikkei Stock Average rebounds for the first time in 4 days, commodity market conditions are high and resource-related is high, but semiconductor-related matters are soft
    2
    Recently, Tesla has gradually declined, and the gap with other large technology stocks has widened more and more, and it is often “disliked” by Wall Street analysts. In a recent example, Wells Fargo recently lowered Tesla's target share price and recommended a reduction in holdings.
    However, I'm a big Tesla fan,US Investment Bank WedbushDan Ives, a well-known strategist, and his team have stated that the market is excessively bearish on Tesla shares, and Tesla shares are likely to rise 77% over the next 12 months.
    According to the latest report, “Since demand for Tesla has become more stable during the remaining period of 2024 and price cuts have slowed down, I believe that battery cost/production shows strong cost efficiency. Furthermore, the company plans to launch Model 2 next year, priced below $30,000. All of these are positive signals for stock prices to rebound.”
    Nonetheless, he pointed out that Tesla is still facing many issues in the short term, such as sluggish demand for electric vehicles, “price competition” that is worsening profit margins, the temporary closure of the Berlin Plant, and disputes over Mr. Musk's reward system...
    Translated
    shintaka1168 commented on
    Last week’s PDUFAs:
    $BeiGene(BGNE.US)$ : Approved 3/8 🎉
    ⇒ BRUKINSA + obinutuzumab
    ⇒ Follicular Lymphoma
    ⇒ sNDA
    ⇒ PDUFA date: Mar 2024
    $Bristol-Myers Squibb(BMY.US)$ : Approved 3/8 🎉
    ⇒ Opdivo ®  + Cisplatin & Gemcitabine
    ⇒ Urothelial carcinoma
    ⇒ sBLA
    ⇒ PDUFA: 04/05/24
    $Vanda Pharmaceuticals(VNDA.US)$ : CRL 3/4 🙁
    ⇒ HETLIOZ® 
    ⇒ insomnia
    ⇒ sNDA
    ⇒ PDUFA: 03/04/24
    $Eyenovia(EYEN.US)$ : Approved 3/4 🎉
    ⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
    ⇒ postop eye pa...
    4 PDUFA decisions this week!
    4 PDUFA decisions this week!
    2
No more